Recommended Antibiotics for MRSA Infections
Vancomycin is the first-line treatment for most serious MRSA infections, with a dosing regimen of 15-20 mg/kg/dose IV every 8-12 hours based on actual body weight, targeting trough concentrations of 15-20 μg/mL for serious infections. 1
Treatment by Infection Type
Skin and Soft Tissue Infections
- For simple abscesses or boils, incision and drainage alone may be sufficient without antibiotics 2
- For purulent cellulitis, recommended oral options include:
- For severe skin infections requiring IV therapy, vancomycin 15-20 mg/kg/dose every 8-12 hours is recommended 3, 1
Bacteremia and Endocarditis
- Vancomycin is the first-line agent, dosed at 15-20 mg/kg/dose every 8-12 hours with target trough concentrations of 15-20 μg/mL 3, 1
- For persistent MRSA bacteremia or vancomycin treatment failures:
Pneumonia
- Linezolid 600 mg PO/IV twice daily is preferred for MRSA pneumonia 1, 5
- Vancomycin can be used but requires higher dosing to achieve adequate lung penetration 6
- Daptomycin should not be used for pneumonia due to inactivation by pulmonary surfactant 1
Central Nervous System Infections
- For brain abscess, subdural empyema, or spinal epidural abscess:
Vancomycin Dosing and Monitoring
- Initial dosing: 15-20 mg/kg/dose (actual body weight) every 8-12 hours, not to exceed 2 g per dose 3, 1
- For serious infections (bacteremia, endocarditis, osteomyelitis, meningitis, pneumonia, severe SSTI):
- For less severe skin infections with normal renal function:
- Trough monitoring is recommended for:
Alternative Agents for MRSA
- Linezolid 600 mg PO/IV twice daily:
- Daptomycin 4-6 mg/kg/day IV:
- TMP-SMX:
- Clindamycin:
Special Considerations
- For vancomycin MIC ≥2 μg/mL (VISA or VRSA), an alternative to vancomycin should be used 3, 1
- For persistent MRSA bacteremia despite adequate vancomycin therapy, consider alternative agents regardless of MIC 3, 1
- Tissue penetration of vancomycin may be reduced in patients with decreased vascular perfusion, such as those with lower-limb infections 8
- Combination therapy with vancomycin plus rifampin has shown better clinical success rates than vancomycin alone in some studies 5
Pediatric Considerations
- Vancomycin 15 mg/kg/dose IV every 6 hours is recommended for serious infections 3, 1
- Clindamycin 10-13 mg/kg/dose IV every 6-8 hours, not to exceed 40 mg/kg/day 1
- Linezolid 10 mg/kg/dose every 8 hours for children <12 years 2
Common Pitfalls to Avoid
- Underdosing vancomycin in critically ill patients - traditional dosing of 1 g every 12 hours is unlikely to achieve target trough concentrations of 15-20 mg/mL 6
- Failure to perform adequate incision and drainage of abscesses, which is essential for successful treatment 2
- Not considering local resistance patterns when selecting empiric therapy 2
- Using daptomycin for pneumonia, where it is ineffective due to inactivation by pulmonary surfactant 1